Cargando…

Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Agirre-Lizaso, Aloña, Huici-Izagirre, Maider, Urretabizkaia-Garmendia, Josu, Rodrigues, Pedro M., Banales, Jesus M., Perugorria, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605535/
https://www.ncbi.nlm.nih.gov/pubmed/37894344
http://dx.doi.org/10.3390/cancers15204977
_version_ 1785127097698615296
author Agirre-Lizaso, Aloña
Huici-Izagirre, Maider
Urretabizkaia-Garmendia, Josu
Rodrigues, Pedro M.
Banales, Jesus M.
Perugorria, Maria J.
author_facet Agirre-Lizaso, Aloña
Huici-Izagirre, Maider
Urretabizkaia-Garmendia, Josu
Rodrigues, Pedro M.
Banales, Jesus M.
Perugorria, Maria J.
author_sort Agirre-Lizaso, Aloña
collection PubMed
description SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients. ABSTRACT: Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs’ reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
format Online
Article
Text
id pubmed-10605535
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106055352023-10-28 Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma Agirre-Lizaso, Aloña Huici-Izagirre, Maider Urretabizkaia-Garmendia, Josu Rodrigues, Pedro M. Banales, Jesus M. Perugorria, Maria J. Cancers (Basel) Review SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients. ABSTRACT: Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs’ reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC. MDPI 2023-10-13 /pmc/articles/PMC10605535/ /pubmed/37894344 http://dx.doi.org/10.3390/cancers15204977 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Agirre-Lizaso, Aloña
Huici-Izagirre, Maider
Urretabizkaia-Garmendia, Josu
Rodrigues, Pedro M.
Banales, Jesus M.
Perugorria, Maria J.
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title_full Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title_fullStr Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title_full_unstemmed Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title_short Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
title_sort targeting the heterogeneous tumour-associated macrophages in hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605535/
https://www.ncbi.nlm.nih.gov/pubmed/37894344
http://dx.doi.org/10.3390/cancers15204977
work_keys_str_mv AT agirrelizasoalona targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma
AT huiciizagirremaider targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma
AT urretabizkaiagarmendiajosu targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma
AT rodriguespedrom targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma
AT banalesjesusm targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma
AT perugorriamariaj targetingtheheterogeneoustumourassociatedmacrophagesinhepatocellularcarcinoma